AI prediction of stomach cancer spread to lymph nodes
Part of Cancer, Digestive system clinical trials.
This study uses artificial intelligence to analyze your CT scan and predict whether stomach cancer has spread to lymph nodes behind your belly. The goal is to help doctors decide if you need more extensive surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with stomach cancer (gastric adenocarcinoma).
- You are scheduled to have surgery to remove the tumor (radical gastrectomy).
- You have had a special CT scan of your belly within 3 weeks before surgery.
- You have not had chemotherapy or radiation before this CT scan.
- You are generally well enough to undergo surgery (ECOG score 0-2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an AI tool can predict how well stomach cancer responds to chemotherapy before surgery. It uses CT scans and biopsy images taken before treatment starts to see if the AI can help guide future care.
This study uses artificial intelligence to analyze your preoperative MRI and pathology results to better predict if cervical cancer has spread to pelvic lymph nodes. The goal is to improve future treatment decisions for patients with cervical cancer.
This trial uses artificial intelligence to analyze digital images of tumor tissue to see if cancer has spread to nearby lymph nodes. It aims to improve diagnosis for many types of cancer.
This study uses information from CT scans done before stomach cancer surgery to see if it can predict whether the cancer may come back early. Researchers want to find patterns in the scans that might help doctors plan better follow-up care.
This trial tests a computer-based model that uses CT scans, endoscopic images, and biopsy tissue to predict how well stomach cancer will respond to chemotherapy given before surgery. The goal is to help doctors choose the best treatment for each patient.
This trial uses MRI scans to predict if breast cancer has spread to additional lymph nodes beyond the first one that was biopsied. It may help women who have already had a positive sentinel lymph node biopsy and then had more lymph nodes removed.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.